20172019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Emanuela Pesce is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel

    Tomati, V., Pesce, E., Caci, E., Sondo, E., Scudieri, P., Marini, M., Amato, F., Castaldo, G., Ravazzolo, R., Galietta, L. J. V. & Pedemonte, N., Jan 1 2018, In : Journal of Biological Chemistry. 293, 4, p. 1203-1217 15 p.

    Research output: Contribution to journalArticle

  • Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

    Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 1 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

    Research output: Contribution to journalArticle

  • Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

    Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

    Research output: Contribution to journalArticle

  • Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

    Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

    Research output: Contribution to journalArticle